Omics techniques develop quickly and have made a great contribution to disease study.
Omics data are usually complex. How to analyze the data and mine important information …

Early diagnosis of hepatocellular carcinoma (HCC) remains challenging to date.
Characteristic metabolic deregulations of HCC may enable novel biomarkers discovery for …

Background: Metabolomics plays an important role in providing insight into the etiology and
mechanisms of hepatocellular carcinoma (HCC). This is accomplished by a comprehensive …

BACKGROUND Early diagnosis of hepatocellular carcinoma may help to ensure that
patients have a chance for long-term survival; however, currently available biomarkers lack …

The established biomarker for hepatocellular carcinoma (HCC), serum α-fetoprotein (AFP),
has suboptimal performance in early disease stages. This study aimed to develop a …

Characterizing the metabolic changes pertaining to hepatocellular carcinoma (HCC) in
patients with liver cirrhosis is believed to contribute towards early detection, treatment, and …

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. The lack of effective
screening methods for early diagnosis has been a longstanding bottleneck to improve the …

Metabolomics has been shown to be an effective tool for biomarker screening and pathway
characterization and disease diagnosis. Metabolic characteristics of hepatocellular …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world.
However, current biomarkers that discriminate HCC from liver cirrhosis (LC) are important …

Hepatocellular carcinoma (HCC) is one of the most prevalent malignant cancers worldwide.
Due to the asymptomatic features of HCC at early stages, patients are often diagnosed at …